Press Release
Care New England Arrhythmia Service Performs First Implant of FDA Approved MRI-ICD in Rhode Island |
10/21/2015 |
Care New England Cardiovascular Care is now offering patients the first implantable cardioverter defibrillator (ICD) system approved by the FDA for use with magnetic resonance imaging (MRI) scans. The first implant of this type of device in Rhode Island was performed recently at Memorial Hospital in Pawtucket. Care New England, located in Rhode Island, was founded in 1996 by Butler Hospital, Kent Hospital and Women & Infants Hospital. Memorial Hospital of Rhode Island joined the system as a hospital partner in 2013. Care New England is an integrated health care system that offers a continuum of quality care. The system includes primary care and specialty physicians; three teaching hospitals affiliated with The Warren Alpert Medical School of Brown University, Butler, Memorial and Women & Infants; a community hospital, Kent; a visiting nurse and home care agency, the VNA of Care New England; and Care New England Wellness Center. For more information, visit carenewengland.org. The expansion of cardiovascular services at Care New England comes after a clinical affiliation with Brigham and Women’s Hospital established a comprehensive program at Kent Hospital. Since then, it has grown to include many additional services including advanced cardiovascular imaging modalities such as cardiac CT, the advanced valvular heart disease service, and the advanced heart failure service with transplant consultation. These services are provided by board certified cardiologists and a team of Care New England nurses and clinical support staff. For a full listing of all cardiac services or more information on Care New England cardiovascular care, please visit www.carenewengland.org/cardiology. |
Back |